Free Internal Medicine CME | CMEList.com

 


Major Depressive Disorder (MDD): Updates from the American Psychiatric Association Annual Meeting (APA) 2017 Posted by...Bernard Sklar, MD.
Free Psychiatry CME Credit Hours...1.0.
CME Credits Awarded by....ScientiaCME.
Cost..........Free. 
Instruction Type....Slide-Video Lectures.
Target Audiences....Healthcare professionals specializing in family medicine, internal medicine, mental health, neurology and psychiatry, or those who otherwise commonly care for patients with MDD or related psychiatric diseases.
Educational material last updated...July 18, 2017.
Expiration of CME credit...July 18, 2019.
Financial Support...Valeant.
Major Depressive Disorder (MDD): Updates from the American Psychiatric Association Annual Meeting (APA) 2017 includes major findings about major depressive disorder from APA 2017, including clinical trial data relevant to both community and health-system practice and recognized barriers to implementing those findings in practice.
After reviewing Major Depressive Disorder (MDD), you will be able to:
• Recall the most impactful findings about Major Depressive Disorder (MDD) from the APA 2017 Annual meeting relating to MDD pathophysiology, progression, & prognosis.
• Describe the most impactful findings about MDD from the APA 2017 Annual meeting relating to using the similarities & differences between MDD & bereavement to inform good clinical care.
• Summarize the most impactful findings about MDD from the APA 2017 Annual meeting relating to old, new, emerging, and potential new targets for treating of MDD and apply them to patient cases.

Osteoporosis Management: Advances in Pharmacotherapy Alzheimer's Disease CME
Posted by...Bernard Sklar, MD.
Free Osteoporosis CME Credit Hours...1.0.
CME Credits Awarded by....ScientiaCME.
Cost..........Free. 
Instruction Type....Slide-Video Lectures.
Target Audiences...Endocrinologists, geriatricians, internists; physician assistants, nurse practitioners, nurses, and pharmacists who specialize in those areas of medicine and those who otherwise commonly care for patients with osteoporosis.
Educational material last updated...July 4, 2017.
Expiration of CME credit....July 4, 2019.
Financial Support...Amgen.
Topics covered in After viewing Osteoporosis Management: Advances in Pharmacotherapy, you will be able to:
• Apply the results of diagnostic imaging and pertinent past medical history to determine a given patient's diagnosis of osteoporosis or osteopenia
• Describe the criteria for initiation of pharmacotherapy for osteoporosis treatment and prevention
• Identify investigational pharmacotherapeutic treatments for management of osteoporosis, and describe their mechanisms of action and likely place in therapy
• Describe the challenges associated with treating patients with osteoporosis, focus specifically on the risks (e.g., adverse drug reactions, drug interactions, etc.) of the agents used to treat and prevent osteoporosis and apply the information in optimizing patient care

Alzheimer Disease (AD) and Its Complications: Best Practices, Emerging Therapies, and Barriers to Care Alzheimer's Disease CME
Posted by...Bernard Sklar, MD.
Alzheimer's Disease CME Credit hours...1.0.
CME Credits Awarded by....ScientiaCME.
Cost...........Free.
Instruction Type...Streaming Video Lecture.
Target Audiences...Healthcare professionals specializing in: neurology, gerontology, internal medicine, palliative care, or those who otherwise commonly care for patients with AD or who frequently encounter them or their caregivers in practice.
Educational material updated...December 21, 2015.
Expiration of CME credit...December 21, 2017.
Financial Support...AVANIR.
Topics covered in Alzheimer Disease (AD) and Its Complications include:
Epidemiology of and risk factors for Alzheimer Disease (AD), Symptomatology and diagnosis of AD, Treatment in patients with AD, Complications and barriers to optimal care in patients with AD and many more.
After completing Alzheimer Disease (AD) and Its Complications, you will be able to:
• Describe what is presently known about the pathophysiology of AD and the challenges associated with diagnosis and treatment of AD.
• Evaluate a treatment plan for a specific patient based on degree of AD to optimize safety and efficacy, suggesting modifications for improvement.
• Identify the present treatment options currently available for management of AD and apply them to patient cases using evidence-based medicine.
• Describe emerging drug therapies in the treatment of AD.
• Describe barriers to care and suggest therapies for treating cognitive and behavioral complications secondary to AD 
In order to get credit from ScientiaCME, you must first establish a username and password.